Pharmacokinetics safety and efficacy of elvitegravircobicistatemtricitabinetenofovir alafenamide in children with HIV aged from 2 years and weighing at least 14 kg

dc.article.end-page6en
dc.article.start-page1en
dc.citation.doi10.1002/JIA2.26414en
dc.contributor.authorE Natukundaen
dc.contributor.authorA Gauren
dc.contributor.authorP Kosalaraksaen
dc.contributor.authorE Hellströmen
dc.contributor.authorRenate Strehlauen
dc.contributor.authorAfaaf Libertyen
dc.contributor.authorE et alen
dc.date.accessioned2026-04-07T11:54:26Z
dc.facultyFACULTY OF HEALTH SCIENCESen
dc.identifier.citationWOSen
dc.identifier.urihttps://hdl.handle.net/10539/48901
dc.journal.titlePharmacokinetics safety and efficacy of elvitegravircobicistatemtricitabinetenofovir alafenamide in children with HIV aged from 2 years and weighing at least 14 kgen
dc.journal.volume28en
dc.publisherINT AIDS SOCIETYen
dc.titlePharmacokinetics safety and efficacy of elvitegravircobicistatemtricitabinetenofovir alafenamide in children with HIV aged from 2 years and weighing at least 14 kgen
dc.typeJournal Articleen

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Journal Article.pdf
Size:
155.41 KB
Format:
Adobe Portable Document Format
Description:
Bitstream uploaded by REST Client